Where is the next Chinese drug that will make MNCs compete to grab orders?
HONG KONG, Jan 9, 2025 – (ACN Newswire via SeaPRwire.com) – The trading of TCE (T Cell Engager) bispecific antibodies remains hot, and multinational pharmaceutical companies (MNCs) are still placing orders frantically. Recently, Candid Therapeutics, an American pharmaceutical company focusing […]















